Concepedia

Gopinath Ganji

GG

Statistics

Publications

11

Citations

3K

H-Index

11

Active since

2006

Affiliations

GlaxoSmithKline (United States)(Current)

Memorial Sloan Kettering Cancer Center

Cornell University

Huntsman Cancer Institute

GlaxoSmithKline (United Kingdom)

Gopinath Ganji is an author at GlaxoSmithKline (United States) specializing in medicine, cell biology, and tumor biology.

Top concepts

Publications per year

2006–2021

11

Publications

11

EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations

Michael T. McCabe, Heidi M. Ott, Gopinath Ganji et al. · Nature · 2012 · 1.8K citations

, , +10

Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27)

Michael T. McCabe, Alan P. Graves, Gopinath Ganji et al. · Proceedings of the National Academy of Sciences · 2012 · 481 citations · Full text

, , +20

BET Inhibition Silences Expression of MYCN and BCL2 and Induces Cytotoxicity in Neuroblastoma Tumor Models

Anastasia Wyce, Gopinath Ganji, Kimberly N. Smitheman et al. · PLoS ONE · 2013 · 203 citations · Full text

, , +14

Response to ERBB3-Directed Targeted Therapy in <i>NRG1</i> -Rearranged Cancers

Alexander Drilon, Romel Somwar, Biju Mangatt et al. · Cancer Discovery · 2018 · 198 citations · Full text

A First-Time-in-Human Study of GSK2636771, a Phosphoinositide 3 Kinase Beta-Selective Inhibitor, in Patients with Advanced Solid Tumors

Joaquı́n Mateo, Gopinath Ganji, Charlotte Lemech et al. · Clinical Cancer Research · 2017 · 138 citations · Full text

1–5 of 11